Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy

Published:2018-07 Issue:4 Volume:8 Page:511-517
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Qi Xiao-Mei,Wang Fang,Mortensen Matthew,Wertz Ryan,Chen Guan

Funder

U.S. Department of Defense

U.S. Department of Veterans Affairs

Nurses Organization of Veterans Affairs

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference83 articles.

1. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road;Caunt;Nat Rev Cancer,2015

2. The dynamic control of signal transduction networks in cancer cells;Kolch;Nat Rev Cancer,2015

3. The importance of kinase-phosphatase integration: lessons from mitosis;Gelens;Trends Cell Biol,2018

4. Scaffold proteins: hubs for controlling the flow of cellular information;Good;Science,2011

5. A dimerization-dependent mechanism drives RAF catalytic activation;Rajakulendran;Nature,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling biological processes and EGFR pathway regulation by the protein tyrosine phosphatase PTPRH in non-small cell lung cancer;2024-06-16

2. p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease;Cells;2023-06-21

3. TrkA Co-Receptors: The Janus Face of TrkA?;Cancers;2023-03-23

4. Characterization of the Molecular Alterations Induced by the Prolonged Exposure of Normal Colon Mucosa and Colon Cancer Cells to Low-Dose Bisphenol A;International Journal of Molecular Sciences;2022-10-01

5. Cisplatin causes covalent inhibition of protein-tyrosine phosphatase 1B (PTP1B) through reaction with its active site cysteine: Molecular, cellular and in vivo mice studies;Biomedicine & Pharmacotherapy;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3